title: Combined modality therapy improves overall survival for angiosarcoma.
authors.affiliation: a Department of Radiation Oncology and Molecular Radiation Sciences , Johns Hopkins Hospital , Baltimore , MD , USA.
authors.forename: Colette J
authors.initials: CJ
authors.lastname: Shen
authors.affiliation: a Department of Radiation Oncology and Molecular Radiation Sciences , Johns Hopkins Hospital , Baltimore , MD , USA.
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Parzuchowski
authors.affiliation: a Department of Radiation Oncology and Molecular Radiation Sciences , Johns Hopkins Hospital , Baltimore , MD , USA.
authors.forename: Megan N
authors.initials: MN
authors.lastname: Kummerlowe
authors.affiliation: b Department of Orthopaedic Surgery , Johns Hopkins Hospital , Baltimore , MD , USA.
authors.forename: Carol D
authors.initials: CD
authors.lastname: Morris
authors.affiliation: c Department of Oncology , Johns Hopkins Hospital , Baltimore , MD , USA.
authors.forename: Christian F
authors.initials: CF
authors.lastname: Meyer
authors.affiliation: d Department of Surgery , Johns Hopkins Hospital , Baltimore , MD , USA.
authors.forename: Mehran
authors.initials: M
authors.lastname: Habibi
authors.affiliation: a Department of Radiation Oncology and Molecular Radiation Sciences , Johns Hopkins Hospital , Baltimore , MD , USA.
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Frassica
authors.affiliation: b Department of Orthopaedic Surgery , Johns Hopkins Hospital , Baltimore , MD , USA.
authors.forename: Adam S
authors.initials: AS
authors.lastname: Levin
authors.affiliation: c Department of Oncology , Johns Hopkins Hospital , Baltimore , MD , USA.|e Center for Sarcoma and Bone Oncology , Dana-Farber Cancer Institute , Boston , MA , USA.
authors.forename: Katherine A
authors.initials: KA
authors.lastname: Thornton
authors.affiliation: a Department of Radiation Oncology and Molecular Radiation Sciences , Johns Hopkins Hospital , Baltimore , MD , USA.
authors.forename: Stephanie A
authors.initials: SA
authors.lastname: Terezakis
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006394:Hemangiosarcoma / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011878:Radiotherapy / Q000379:methods; D012189:Retrospective Studies; D012509:Sarcoma / Q000401:mortality / Q000473:pathology / Q000628:therapy; D012983:Soft Tissue Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D013514:Surgical Procedures, Operative / Q000379:methods; D016019:Survival Analysis; D015996:Survival Rate; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents